Sign in →

Epic Code LAB1230566 Discontinued: APTIMA Panel

Interface Order Alias

1230566

Clinical Information

Chlamydia trachomatis (CT) is the major cause of genital chlamydial infections in men and women.  CT can cause nongonococcal urethritis, epididymitis, proctitis, cervicitis, acute salpingitis, and Pelvic Inflammatory Disease (PID).  CT infections are often asymptomatic in both males and females.  Children born to infected mothers are at significantly higher risk for inclusion conjunctivitis and chlamydial pneumonia.

N. gonorrhoeae is the causative agent of gonococcal (GC) infections, the majority of which are uncomplicated lower genital tract infections and may be asymptomatic.  However, if left untreated in women, infections can ascend and cause PID which can manifest as endometriosis, salpingitis, pelvic peritonitis, and tubo-ovarian abscesses.  A smaller percentage of persons with gonococcal infections may develop disseminated Gonococcal Infection.

Trichomonas vaginalis (TV) is the most common curable sexually transmitted disease (STD) agent in the United States.  Infection with the protozoa in women can cause vaginitis, urethritis, and cervicitis.  Complications can include premature labor, low-birth-weight offspring, premature rupture of membranes, and post-abortion or post-hysterectomy infection.

The Mycoplasma genitalium assay uses the APTIMA target nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium to aid in the diagnosis of M. genitalium urogenital infections in male and female patients.

Reference Range

Negative

Performing Department

Formerly
CYTOLOGY (Chlamydia, Gonococcus,Trichomonas)
MOLECULAR DIAGNOSTICS (Mycoplasma/MGen)

Performing Department Laboratory Location

Corewell Health Reference Laboratory, Grand Rapids, MI

Corewell Health Advanced Technology Laboratory, Grand Rapids, MI

Methodology

The APTIMA Nucleic Acid Amplification Test (NAAT) utilizes target capture, Transcription-Mediated Amplification (TMA) and Dual Kinetic Assay (DKA) technologies for the detection of ribosomal RNA (rRNA) from C. trachomatis,  N. gonorrhoeae, T. vaginalis and M. genitalium.

CPT

87661, 87491, 87591, 87563

CDM Code

3008766101, 3068749101, 3068759104, 3068756301

Epic Test ID

1230102183

LOINC

CHLAMYDIA NAAT APTIMA: 43304-5
GONOCOCCUS NAAT APTIMA: 43305-2
MYCOPLASMA NAAT APTIMA: 23300-7
TRICHOMONAS NAAT APTIMA: 46154-1

Reviewed Date

3/23/2022

Updated Date

8/27/2024 - Discontinued